Fish Oils for the Secondary Prevention of Coronary Heart Disease
Deloitte Access Economics February 2012
Commissioned by CHC
The Complementary Healthcare Council of Australia commissioned Deloitte Access Economics to undertake a cost-benefit analysis to assess the economic merits of providing fish oils supplements to Australians who have had a heart attack. This analysis estimated the net benefit of fish oils as adjunctive treatment for prevention of heart disease according to the current clinical evidence, compared to standard of care without fish oils supplements. The analysis took into account the cost per person of the treatment and the disability-adjusted life years (DALYs) avoided.
to access the full report.
A one page summary document is also available on request.
The findings of this research were officially released at the launch of the CHC Business to Business magazine, Complementary Medicines Today, in Sydney on February 28 2012.
For more information about the CHC Business magazine, or to receive a free copy, please contact us.